Bavarian Nordic A/S (BVNRY)
OTCMKTS
· Delayed Price · Currency is USD
8.25
-0.01 (-0.06%)
May 12, 2025, 3:53 PM EDT
Bavarian Nordic Employees
Bavarian Nordic had 1,605 employees as of December 31, 2024. The number of employees increased by 226 or 16.39% compared to the previous year.
Employees
1,605
Change (1Y)
226
Growth (1Y)
16.39%
Revenue / Employee
$548,850
Profits / Employee
$116,369
Market Cap
1.93B
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Endo Inc. | 3,116 |
| Tian'an Technology Group | 8 |
| CytoDyn | 9 |
| Glass House Brands | 374 |
| Elite Pharmaceuticals | 64 |
| Northwest Biotherapeutics | 25 |
| American Oncology Network | 1,914 |
| Silence Therapeutics | 116 |
Bavarian Nordic News
- 3 days ago - Bavarian Nordic A/S (BVNKF) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 3 days ago - Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with such - GlobeNewsWire
- 3 days ago - Bavarian Nordic A/S 2025 Q1 - Results - Earnings Call Presentation - Seeking Alpha
- 4 days ago - Bavarian Nordic A/S reports interim Q1 results - Seeking Alpha
- 4 days ago - Bavarian Nordic Announces Interim Results for the First Three Months of 2025 - GlobeNewsWire
- 7 days ago - Bavarian Nordic Awarded Contract Options from the U.S. Government for Production and Supply of Freeze-dried Smallpox/Mpox Vaccines - GlobeNewsWire
- 11 days ago - Bavarian Nordic Receives Marketing Authorization for Chikungunya Vaccine for Persons Aged 12 and Older in the United Kingdom - GlobeNewsWire
- 26 days ago - Bavarian Nordic's Chikungunya Vaccine Receives Recommendation from U.S. CDC's Advisory Committee on Immunization Practices (ACIP) - GlobeNewsWire